Helicobacter pylori infection is associated with the seriousness of carotid atherosclerosis and inflammatory

Hong Zhao1, Yemeng Chu2, Ying Li1

  • 1Department of Neurology, Dalian Central Hospital Affiliated to Dalian University of Technology, No.826 Southwest Road, Shahekou District, Dalian City, Liaoning Province 116033, China.

Insights

Helicobacter pylori (Hp) infection is linked to carotid atherosclerosis and its severity. Hp seropositivity correlates with increased inflammation markers like Lp-PLA2 and MMP-9, suggesting a role in stroke risk.

Area of Science:

  • Cardiovascular Science
  • Infectious Disease Epidemiology
  • Biomarkers in Atherosclerosis

Background:

  • Carotid atherosclerosis is a major risk factor for ischemic stroke.
  • The role of Helicobacter pylori (Hp) infection in atherosclerosis remains debated.
  • This study investigates Hp seroprevalence and its association with carotid atherosclerosis severity.

Purpose of the Study:

  • To determine Hp seroprevalence in patients with carotid atherosclerosis.
  • To assess the correlation between Hp seropositivity and carotid artery stenosis severity.
  • To explore the potential role of inflammatory markers (Lp-PLA2, MMP-9) in Hp-associated atherosclerosis.

Main Methods:

  • Enzyme-linked immunosorbent assay (ELISA) used for Hp IgG detection.
  • Participants classified into mild, moderate, and severe carotid stenosis groups.
  • Measurement of serum cytokines: lipoprotein-associated phospholipase A2 (Lp-PLA2) and metalloproteinase-9 (MMP-9).

Main Results:

  • Hp seropositivity was significantly higher in carotid atherosclerosis patients (62.8%) compared to controls (32.1%).
  • Higher Hp seropositivity correlated with increased carotid atherosclerosis severity and elevated Lp-PLA2 and MMP-9 levels.
  • Hp-positive patients exhibited higher total cholesterol and LDL-C levels.

Conclusions:

  • Hp seropositivity is significantly correlated with the presence and severity of carotid atherosclerosis.
  • Chronic Hp infection may contribute to atherosclerosis through lipid alterations and increased pro-inflammatory cytokines.
  • Reducing Hp burden could potentially decrease cerebrovascular events.
Abstract

Related Concept Videos

Pathophysiology of Peptic Ulcer Disease: Injurious Factors01:22

Pathophysiology of Peptic Ulcer Disease: Injurious Factors

Peptic ulcers are sores on the stomach's inner lining and the upper small intestine, which are the result of disruptions in the mucosal layer that houses parietal cells which produce gastric acid, and chief cells which secrete pepsinogen.
In the antrum region, G cells secrete the gastrin hormone that binds to gastrin-cholecystokinin-B (CCK2) receptors on parietal and enterochromaffin-like (ECL) cells in the fundic glands. Simultaneously, the vagus nerve releases acetylcholine, which binds...
1.1K
Peptic Ulcer Disease I: Introduction01:30

Peptic Ulcer Disease I: Introduction

Peptic Ulcer Disease (PUD) is characterized by mucosal excavation in the esophagus, stomach, pylorus, or duodenum. It can manifest as acute or chronic based on the extent and duration of mucosal involvement.
An acute ulcer, marked by superficial erosion and minimal inflammation, swiftly resolves upon identifying and addressing the underlying cause. In contrast, a chronic ulcer persists, potentially eroding through the muscular wall and forming fibrous tissue.
Peptic ulcers can also be...
711
Gastritis-II: Pathophysiology01:17

Gastritis-II: Pathophysiology

Gastritis is marked by disruption of the mucosal barrier that usually protects the stomach tissue from digestive juices and manifests in acute and chronic forms.
In acute gastritis, the gastric mucosa becomes swollen and red and undergoes superficial erosion. Superficial ulceration may lead to bleeding.
In chronic gastritis, persistent or repeated insults lead to chronic inflammatory changes and, eventually, thinning or atrophy of the gastric tissue.
Gastritis can stem from various causes, each...
1.1K
Peptic Ulcer Disease III: Clinical Manifestations and Diagnostic Studies01:28

Peptic Ulcer Disease III: Clinical Manifestations and Diagnostic Studies

Peptic ulcer disease (PUD) presents with diverse symptoms depending on the location and severity of the ulcer. Clinical manifestations of peptic ulcer include dull pain and a burning sensation in the mid-epigastric region.
Few clinical manifestations differentiate gastric ulcers from duodenal ulcers. Distinctions in the location, timing, and pain relief are crucial for healthcare providers in differentiating between gastric and duodenal ulcers during clinical assessments.
507
Treating Helicobacter pylori in Peptic Ulcers: Antimicrobial Therapy01:16

Treating Helicobacter pylori in Peptic Ulcers: Antimicrobial Therapy

Helicobacter pylori, a resilient gram-negative bacterium, can thrive in the stomach's harsh, acidic environment. Infection with H. pylori leads to a cascade of events within the stomach lining. One of the critical disruptions caused by this bacterium is the interference with somatostatin production, a hormone responsible for regulating acid secretion. This interference tips the balance, escalating acid secretion and diminishing bicarbonate levels. This imbalance compromises the defensive...
1.1K
Pathophysiology of Peptic Ulcer Disease: Mucosal Defense Factors01:24

Pathophysiology of Peptic Ulcer Disease: Mucosal Defense Factors

Peptic ulcer disease, commonly called PUD, represents a multifaceted condition characterized by disruptions in the lining of the gastrointestinal (GI)  tract. Central to the protection of the gastrointestinal lining is the mucosal-bicarbonate barrier. This physiological defense mechanism is a formidable shield against the corrosive effects of gastric acid and pepsin secretion in the stomach. Its role is pivotal in maintaining the structural integrity of the stomach's inner lining.
1.1K